Log In
Print
BCIQ
Print
Print this Print this
 

Staphylococcus lysin (CF-301)

  Manage Alerts
Collapse Summary General Information
Company ContraFect Corp.
DescriptionStaphylococcal-specific lysin protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase I
Standard IndicationStaphylococcus
Indication DetailsTreat acute bacterial skin and skin structure infections (ABSSSI) caused by Staphylococcus aureus; Treat Staphylococcus infections
Regulatory Designation U.S. - Fast Track (Treat Staphylococcus infections)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today